<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Piracetam for reducing the incidence of painful sickle cell disease crises - Al Hajeri, A - 2016 | Cochrane Library</title> <meta content="Piracetam for reducing the incidence of painful sickle cell disease crises - Al Hajeri, A - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006111.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Piracetam for reducing the incidence of painful sickle cell disease crises - Al Hajeri, A - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006111.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006111.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Piracetam for reducing the incidence of painful sickle cell disease crises" name="citation_title"/> <meta content="Amani Al Hajeri" name="citation_author"/> <meta content="Ministry of Health" name="citation_author_institution"/> <meta content="alhajeriamani@gmail.com" name="citation_author_email"/> <meta content="Zbys Fedorowicz" name="citation_author"/> <meta content="Veritas Health Sciences Consultancy Ltd" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD006111.pub3" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/02/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006111.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006111.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006111.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anemia, Sickle Cell [complications, *drug therapy]; Antisickling Agents [*therapeutic use]; Pain [*drug therapy]; Piracetam [*therapeutic use]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006111.pub3&amp;doi=10.1002/14651858.CD006111.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="uQyIsxpV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006111\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006111\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","hr","ru","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006111.pub3",title:"Piracetam for reducing the incidence of painful sickle cell disease crises",firstPublishedDate:"Feb 12, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Cystic Fibrosis and Genetic Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006111.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006111.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006111.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006111.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006111.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006111.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006111.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006111.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006111.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006111.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006111.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006111.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006111.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006111.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1419 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006111.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/full#CD006111-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/full#CD006111-sec-0085"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/full#CD006111-sec-0008"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/full#CD006111-sec-0013"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/full#CD006111-sec-0014"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/full#CD006111-sec-0040"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/full#CD006111-sec-0084"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006111.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006111.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Piracetam for reducing the incidence of painful sickle cell disease crises</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/information#CD006111-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Amani Al Hajeri</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006111.pub3/information#CD006111-cr-0005">Zbys Fedorowicz</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006111.pub3/information/en#CD006111-sec-0096">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 February 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006111.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006111.pub3">https://doi.org/10.1002/14651858.CD006111.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006111-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006111-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006111-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006111-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006111-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006111-abs-0001" lang="en"> <section id="CD006111-sec-0001"> <h3 class="title" id="CD006111-sec-0001">Background</h3> <p>Sickle cell disease is one of the most common genetic disorders. Sickle cell crises in which irregular and dehydrated cells contribute to blocking of blood vessels are characterised by episodes of pain. Treatment is mainly supportive and symptomatic. <i>In vitro</i> studies with piracetam indicate that it has the potential for inhibition and a reversal of the process of sickling of erythrocytes. This is an update of a previously published Cochrane review. </p> </section> <section id="CD006111-sec-0002"> <h3 class="title" id="CD006111-sec-0002">Objectives</h3> <p>To assess the effectiveness of piracetam for reducing the incidence of painful sickle cell disease crises. </p> </section> <section id="CD006111-sec-0003"> <h3 class="title" id="CD006111-sec-0003">Search methods</h3> <p>We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Haemoglobinopathies Trials Register which comprises of references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings. </p> <p>Last search of the Group's Haemoglobinopathies Trials Register: 21 September 2015.</p> </section> <section id="CD006111-sec-0004"> <h3 class="title" id="CD006111-sec-0004">Selection criteria</h3> <p>Randomised controlled trials comparing orally administered piracetam to placebo or standard care in people, of all ages and both sexes, with sickle cell disease. </p> </section> <section id="CD006111-sec-0005"> <h3 class="title" id="CD006111-sec-0005">Data collection and analysis</h3> <p>Two authors independently assessed trial quality and extracted data. Trial authors were contacted for additional information. Adverse effects data were collected from the trials. </p> </section> <section id="CD006111-sec-0006"> <h3 class="title" id="CD006111-sec-0006">Main results</h3> <p>Three trials involving 169 participants were included in the review. A limited amount of data addressing some of the primary and some of the secondary outcomes were provided, but data were incomplete and based on un‐validated assumptions used in the evaluation of outcomes. One trial reported a reduction in the number of pain crises and their severity with active intervention than placebo but presented no data to confirm these results. A second trial presented a monthly global pain score based on the number of sickle cell crises and severity of pain but included no separate data for these primary outcomes. Although there was no significant difference between the piracetam and placebo periods for the number of days of hospitalisation (P = 0.87) in one trial, inconsistencies in the criteria necessary for hospitalisation during sickle crises did not permit accurate conclusions to be drawn. Two of the trials reported participant satisfaction with piracetam but provided no details as to how this satisfaction had been assessed. There were no reports of toxicity or adverse effects with piracetam other than one participant who experienced dizziness. </p> </section> <section id="CD006111-sec-0007"> <h3 class="title" id="CD006111-sec-0007">Authors' conclusions</h3> <p>The small number of included trials and their poor methodological quality provided insufficient reliable evidence to support the routine use of this medication for preventing the incidence of painful sickle cell disease crises. </p> <p>We will continue to run searches to identify any potentially relevant trials; however, we do not plan to update other sections of the review until new trials are published. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006111-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006111-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006111-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006111-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD006111-abs-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006111-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD006111-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006111-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006111-abs-0002" lang="en"> <h3>Piracetam for reducing the incidence of painful sickle cell disease crises</h3> <p><b>Review question</b> </p> <p>We reviewed the evidence to assess the effectiveness of piracetam for reducing the incidence of painful sickle cell disease crises. This is an update of a previously published Cochrane review. </p> <p><b>Background</b> </p> <p>Sickle cell disease is one of the most common genetic disorders and affects about 250 million people (5% of the world's population). It is characterised by sickle‐shaped red blood cells which may block blood vessels. This can lead to pain and damage to the major organs such as the brain, liver and spleen. Standard care is mainly supportive and in response to symptoms. Pain is controlled with drugs for pain relief and fluids to improve fluid levels. In vitro studies with piracetam have shown that it hinders the bonding of sickle haemoglobin and the bunching together of platelets. It also makes the blood less sticky and red blood cells more flexible. </p> <p><b>Search date</b> </p> <p>The evidence is current to: 21 September 2015.</p> <p><b>Key results</b> </p> <p>The authors of the review identified three trials, two of which had a cross‐over design. The quality of the trials was poor. There were wide differences in the people taking part, the drug dose and the outcomes measured. Three trials are included. They provide some weak and unreliable evidence that piracetam prevents painful sickle cell crises. This lack of reliable evidence illustrates some of the doubt and lack of support for the routine use of this treatment for reducing the incidence of painful sickle cell disease crises. The review authors conclude that future research should aim to provide evidence for people to make informed decisions about whether piracetam is of use. Further randomised controlled trials should be well‐designed and reported according to the 'Consolidated Standards of Reporting Trials (CONSORT)' statement. </p> <p>We will continue to run searches to identify any potentially relevant trials; however, we do not plan to update other sections of the review until new trials are published. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006111-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006111-sec-0085"></div> <h3 class="title" id="CD006111-sec-0086">Implications for practice</h3> <section id="CD006111-sec-0086"> <p>There is insufficient evidence to support the routine use of this medication for reducing the incidence of painful sickle cell disease crises. </p> </section> <h3 class="title" id="CD006111-sec-0087">Implications for research</h3> <section id="CD006111-sec-0087"> <p>Future research should aim to provide evidence for people to make informed decisions about whether piracetam is effective and therefore any further randomised controlled trials should use larger samples, longer intervention and washout periods if appropriate, include a lengthier follow‐up period and be reported according to the <a href="http://www.consort-statement.org" target="_blank">Consolidated Standards of Reporting Trials (CONSORT) statement</a>. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006111-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006111-sec-0008"></div> <section id="CD006111-sec-0009"> <h3 class="title" id="CD006111-sec-0009">Prevalence and aetiology</h3> <p>Sickle cell disease is one of the most common genetic disorders, affecting primarily people of African, Mediterranean, Middle Eastern and Indian descent. Approximately 250 million people (5% of the world's population) carry a potentially pathological haemoglobinopathy gene (<a href="./references#CD006111-bbs2-0031" title="World Health Organization. Sickle-cell anaemia. Report A59/9. Provisional agenda item 11.4. 59th World Health Assembly. www.who.int/gb/ebwha/pdf_files/WHA59/A59_9-en.pdf (accessed 15 February 2006).">WHO 2006</a>). In the USA there are approximately 75,000 African‐Americans (<a href="./references#CD006111-bbs2-0025" title="National Institutes of Health National Heart, Lung and Blood Institute. The Management of Sickle Cell Disease. NIH Publication No. 02-21172002.">NIH 2002</a>) and in the UK 10,000 British people living with sickle cell disease (<a href="./references#CD006111-bbs2-0014" title="DaviesSC , OniL . The management of patients with sickle cell disease. BMJ1997;315(7109):656-60.">Davies 1997</a>). As a result of under‐reporting, genetic diseases are likely to be systematically underestimated in developing countries, but some reliable data are available. In the Middle East, e.g. Bahrain, the burden of disease is quite high; 1% to 2% of all neonates have sickle cell disease, whilst 11% of the total are carriers of the disease (<a href="./references#CD006111-bbs2-0009" title="Al-ArrayedSS , HaitesN . Features of sickle-cell disease in Bahrain. Eastern Mediterranean Health Journal1995;1(1):112-9.">Al‐Arrayed 1995</a>). Several of the neighbouring countries have indicated similar levels of sickle cell disease in their populations, but comprehensive and up‐to‐date information is scanty and often unavailable. </p> <p>Sickle cell disease occurs when the haemoglobin variant HbS gene is inherited from both parents (HbSS), which is the most prevalent form of the disease (<a href="./references#CD006111-bbs2-0028" title="SerjeantGR , SerjeantBE . Sickle Cell Disease. 3rd edition. Oxford: Oxford University Press, 2001.">Serjeant 2001</a>) or from one parent in combination with another haemoglobin variant gene such as (HbSC) or sickle‐ß‐thalassaemia (S‐ß‐Thal). People with homozygous sickle cell disease (HbSS) have a mutated beta globin gene (bS), which causes the production of abnormal sickle haemoglobin. </p> <p>The disease is characterised by the presence of distorted sickle‐shaped red blood cells in the blood stream. These arise as a result of the polymerisation (a gelling of the molecules) of the abnormal haemoglobin in the red blood cells when they release their combined oxygen. The accompanying red blood cell dehydration then tends to increase the intracellular concentration of the sickle haemoglobin which may in turn lead to further polymerisation. The presence of these dense, irregular and fragile dehydrated cells can contribute to blocking of blood vessels (vaso‐occlusion) which can lead to pain episodes also known as crises, and may even cause damage to major organs. </p> </section> <section id="CD006111-sec-0010"> <h3 class="title" id="CD006111-sec-0010">Symptoms</h3> <p>Most manifestations of the disease are attributed to either premature red cell destruction (haemolysis) or obstruction of blood flow (vaso‐occlusion). Vaso‐occlusive crises can produce pain particularly in muscles, bone and joints. Severe vaso‐occlusion leading to splenic infarction may result in an increased vulnerability to severe infections and exceptionally to acute splenic sequestration (<a href="./references#CD006111-bbs2-0027" title="SerjeantGR . The geography of sickle-cell disease: opportunity for understanding its diversity. Annals of Saudi Medicine1994;14:237-46.">Serjeant 1994</a>). </p> <p>Life‐threatening complications will require hospitalisation (<a href="./references#CD006111-bbs2-0011" title="BalkaranB , CharG , MorrisJS , SerjeantBE , SerjeantGR . Stroke in a cohort study of patients with homozygous sickle cell disease. Journal of Pediatrics1992;120(3):360-6.">Balkaran 1992</a>) and can include acute chest syndrome (<a href="./references#CD006111-bbs2-0013" title="CastroO , BrambillaDJ , ThoringtonB , ReindorfCA , ScottRB , GilletteP , et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. Blood1994;84(2):643-9.">Castro 1994</a>), splenic sequestration (<a href="./references#CD006111-bbs2-0029" title="TopleyJM , RogersDW , StevensMC , SerjeantGR . Acute splenic sequestration and hypersplenism in the 5 years of life in homozygous sickle cell disease. Archives of Disease in Childhood1981;56(10):765-9.">Topley 1981</a>) in addition to the more chronic events of later life resulting from renal disease and heart failure. Children are at exceptional risk of cognitive impairment as a result of the neurological changes which can occur with overt and subclinical strokes (<a href="./references#CD006111-bbs2-0023" title="KnightS , SinghalA , ThomadsP , SerjeantGR . Factors associated with lowered intelligence in homozygous sickle cell disease. Archives of Disease in Childhood1995;73(4):316-20.">Knight 1995</a>). </p> <p>Pain is one of the most common symptoms in sickle cell disease. Its onset and severity is unpredictable and recurrent acute episodes can occur throughout life and may require pain medication and hospitalisation (<a href="./references#CD006111-bbs2-0012" title="BrozovicM , DaviesSC . Management of sickle cell disease. Postgraduate Medical Journal1987;63(742):605-9.">Brozovic 1987</a>). </p> </section> <section id="CD006111-sec-0011"> <h3 class="title" id="CD006111-sec-0011">Treatment options</h3> <p>Standard care for sickle cell crises is mainly supportive and symptomatic, utilising analgesics and hydration for pain control, and may include transfusion for anemia. Prophylaxis with daily oral penicillin has been used to reduce the rate of infection and the mortality related to pneumococcal infection (<a href="./references#CD006111-bbs2-0015" title="DaviesEG , RiddingtonC , LottenbergR , DowerN . Pneumococcal vaccines for sickle cell disease. Cochrane Database of Systematic Reviews2004, Issue 1. Art. No: CD003885. [DOI: 10.1002/14651858.CD003885.pub2]">Davies 2004</a>). Antibiotic therapy should be used to treat resulting infections and the administration of oxygen has been said to be useful in helping relieve some of the symptoms of acute chest syndrome (<a href="./references#CD006111-bbs2-0014" title="DaviesSC , OniL . The management of patients with sickle cell disease. BMJ1997;315(7109):656-60.">Davies 1997</a>). Attempts at finding a drug to prevent the red cells from sticking to the walls of blood vessels and each other have had limited success and the options for a successful cure are few. </p> <p>Hydroxyurea, the subject of another Cochrane Review, is known to raise foetal haemoglobin and decrease cellular dehydration. It has been shown to be both effective and safe in severely affected SS adults but also has recognised side effects such as cytopenia (low white cell or platelet count) and occasional nausea (<a href="./references#CD006111-bbs2-0022" title="JonesAP , DaviesS , OlujohungbeA . Hydroxyurea for sickle cell disease. Cochrane Database of Systematic Reviews2001, Issue 2. Art. No: CD002202. [DOI: 10.1002/14651858.CD002202]">Jones 2001</a>). </p> </section> <section id="CD006111-sec-0012"> <h3 class="title" id="CD006111-sec-0012">Piracetam</h3> <p>Piracetam (2‐oxo‐l‐pyrrolidine acetamide, Nootropyl), a cyclic derivative of gamma‐amino butyrate has been used for the treatment of mental function and dyslexia and as it has no known side effects (<a href="./references#CD006111-bbs2-0030" title="VernonMW , SorkinEM . Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders. Drugs and Aging1991;1(1):17-35.">Vernon 1991</a>) and in view of its anti‐sickling effect in vivo (<a href="./references#CD006111-bbs2-0024" title="MoriauM , CrasbornL , Lavenne-PardongeE , vonFrenckellR , Col-DebeysC . Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects. Arzneimittelforschung1993;43(2):110-8.">Moriau 1993</a>) has been considered as a possible therapeutic agent for management of sickle cell disease crises. Most of the in vitro studies with piracetam, have shown that it interferes with HbS polymerisation, causes a reduction in blood viscosity, an increase in erythrocyte elasticity, inhibits platelet aggregation (<a href="./references#CD006111-bbs2-0010" title="AsakuraT , OhnishiST , AdachiK , OzgucM , HashimotoK , DevlinMT , et al. Effect of piracetam on sickle erythrocytes and sickle hemoglobin. Biochimica et Biophysica Acta1981;668(3):397-405.">Asakura 1981</a>; <a href="./references#CD006111-bbs2-0007" title="GiniEK , SonnetJ . Use of piracetam improves sickle cell deformability in vivo. Journal of Clinical Pathology1987;40(1):99-102. ">Gini 1987</a>) and has the potential for inhibition and a reversal of the process of sickling of erythrocytes (<a href="./references#CD006111-bbs2-0016" title="deAraujoJT , NeroGS . Piracetam and acetamide in sickle-cell disease. Lancet1977;2(8034):411.">de Araujo 1977</a>). </p> <p>Several studies on the efficacy of piracetam in sickle cell disease crises have shown conflicting results (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>; <a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>); and this systematic review seeks to assess the available evidence. </p> <p>Thi is an update of a previously published Cochrane review. We will continue to run searches to identify any potentially relevant trials; however, we do not plan to update other sections of the review until new trials are published. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006111-sec-0013" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006111-sec-0013"></div> <p>To evaluate the effectiveness of piracetam for reducing the incidence of painful sickle cell disease crises. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006111-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006111-sec-0014"></div> <section id="CD006111-sec-0015"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006111-sec-0016"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs).</p> </section> <section id="CD006111-sec-0017"> <h4 class="title">Types of participants</h4> <p>People with sickle cell disease SS, SC, Sß<sup>0</sup>, Sß+ (confirmed by electrophoresis and sickle solubility test, with family studies or DNA tests as appropriate) of all ages and both sexes, in any setting. </p> </section> <section id="CD006111-sec-0018"> <h4 class="title">Types of interventions</h4> <p>Piracetam administered orally compared to placebo or standard care for a period of up to two years. </p> </section> <section id="CD006111-sec-0019"> <h4 class="title">Types of outcome measures</h4> <section id="CD006111-sec-0020"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD006111-list-0001"> <li> <p>Number of painful sickle cell disease crises</p> </li> <li> <p>Pain</p> <ol id="CD006111-list-0002"> <li> <p>intensity (expressed as scores obtained through any validated patient reported outcomes instrument either generic or sickle cell disease specific) </p> </li> <li> <p>duration</p> </li> </ol> </li> <li> <p>The requirement for opiate treatment during hospitalisation, Accident &amp; Emergency Department visits or on discharge to home. </p> <ol id="CD006111-list-0003"> <li> <p>dose</p> </li> <li> <p>type</p> </li> <li> <p>frequency</p> </li> </ol> </li> </ol> </p> </section> <section id="CD006111-sec-0021"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD006111-list-0004"> <li> <p>Mortality (number of deaths)</p> </li> <li> <p>Number of life‐threatening complications of sickle cell disease (e.g. stroke, acute chest syndrome, infection and acute splenic sequestration) </p> </li> <li> <p>Red cell dehydration</p> <ol id="CD006111-list-0005"> <li> <p>proportion of dense cells</p> </li> <li> <p>mean corpuscular haemoglobin concentration</p> </li> <li> <p>mean corpuscular volume</p> </li> </ol> </li> <li> <p>Number of other sickle‐related events (e.g. priapism, leg ulceration)</p> </li> <li> <p>Quality of life (e.g. absence from school, lost time at work, mobility) as assessed by any validated questionnaire either generic or sickle cell disease specific </p> </li> <li> <p>Hospitalisation: as the number of inpatient days.</p> </li> <li> <p>Participant satisfaction with the medication assessed by any appropriate and validated questionnaire (either generic or sickle cell disease specific) </p> </li> </ol> </p> </section> <section id="CD006111-sec-0022"> <h5 class="title">Adverse effects</h5> <p>We noted and reported any clinically diagnosed hypersensitivity or toxicity in addition to any reports of unacceptable adverse events associated with this medication. </p> <p>There have been some post hoc changes made to this section, please refer to the <a href="#CD006111-sec-0100">Published notes</a> section for further information. </p> </section> </section> </section> <section id="CD006111-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006111-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We identified relevant trials from the Cochrane Cystic Fibrosis and Genetic Diseases Group's (CFGDG) Haemoglobinopathies Trials Register using the terms: sickle cell AND piracetam. </p> <p>The Haemoglobinopathies Trials Register is compiled from electronic searches of the Cochrane Central Register of Controlled Trials (Clinical Trials) (updated each new issue of <i>The Cochrane Library</i>), and weekly searches of MEDLINE. Unpublished work is identified by searching the abstract books of five major conferences: the European Haematology Association conference; the American Society of Hematology conference; the British Society for Haematology Annual Scientific Meeting; the Caribbean Health Research Council Meetings; and the National Sickle Cell Disease Program Annual Meeting. </p> <p>For full details of all searching activities for the register, please see the relevant section of the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/CF/frame.html" target="_blank">Cystic Fibrosis and Genetic Disorders Review Group Module</a>. </p> <p>Date of the last search of the Group's Haemoglobinopathies Trials Register: 21 September 2015. </p> </section> <section id="CD006111-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We did not handsearch any specific journals but we examined the reference lists of any potential clinical trials and the review authors' personal databases of trial reports in an attempt to identify any additional studies or those not identified in the searches. </p> <p>We contacted investigators of included studies by electronic mail to clarify trial details and asked for information about any additional published and unpublished trials. </p> <p>Although there was no language restriction on included studies we did not find any relevant non‐English papers. </p> </section> </section> <section id="CD006111-sec-0026"> <h3 class="title" id="CD006111-sec-0026">Data collection and analysis</h3> <section id="CD006111-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two authors Amani Al Hajeri (AAH) and Zbys Fedorowicz (ZF) independently assessed the abstracts of studies resulting from the searches. Full copies of all relevant and potentially relevant studies, those appearing to meet the inclusion criteria, or for which there were insufficient data in the title and abstract to make a clear decision were obtained. The full text papers were assessed independently by the two authors and any disagreement on the eligibility of potentially included studies was resolved through discussion and consensus. After assessment by the authors any duplicate publications or remaining studies that did not match the inclusion criteria were excluded from further review and the reasons for their exclusion were noted in the '<a href="./references#CD006111-sec-0103" title="">Characteristics of excluded studies</a>' table. </p> </section> <section id="CD006111-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>The authors collected outcomes data using a pre‐determined form designed for this purpose. Both (AAH and ZF) sequentially entered extracted data into the Review Manager (RevMan) software and automatically checked for differences (<a href="./references#CD006111-bbs2-0026" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). Zbys Fedorowicz (ZF) held the master copy. The authors only included data if there was an independently reached consensus, any disagreements were resolved by consulting with a third author (AO). </p> <p> <ol id="CD006111-list-0006"> <li> <p>Trial methods</p> <ol id="CD006111-list-0007"> <li> <p>method of allocation</p> </li> <li> <p>masking of participants and outcomes</p> </li> <li> <p>exclusion of participants after randomisation and proportion of losses at follow up</p> </li> </ol> </li> <li> <p>Participants</p> <ol id="CD006111-list-0008"> <li> <p>country of origin</p> </li> <li> <p>sample size</p> </li> <li> <p>age</p> </li> <li> <p>sex</p> </li> <li> <p>inclusion and exclusion criteria</p> </li> </ol> </li> <li> <p>Intervention</p> <ol id="CD006111-list-0009"> <li> <p>dose</p> </li> <li> <p>duration and length of time in follow up</p> </li> </ol> </li> <li> <p>Control</p> <ol id="CD006111-list-0010"> <li> <p>control or placebo</p> </li> </ol> </li> <li> <p>Outcomes</p> <ol id="CD006111-list-0011"> <li> <p>primary and secondary outcomes mentioned in the section of outcome measures</p> </li> </ol> </li> </ol> </p> <p>The authors used this information to help them assess heterogeneity and the external validity of the trials. </p> <p>Ghazi Omar Tadmouri (GOT) and Ahmed Omran (AO) graded the selected studies independently and assessed every trial reporting a randomized clinical trial according to the criterion grading system described in the 'Cochrane Handbook for Systematic Reviews of Interventions 4.2.5' (<a href="./references#CD006111-bbs2-0021" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library. The Cochrane Collaboration. Chichester, UK: John Wiley &amp; Sons, Ltd; 2005, Issue 3.2005.">Higgins 2005</a>). These authors compared the gradings and discussed and resolved any inconsistencies in the interpretation of inclusion criteria and their significance to the selected studies. The following parameters of methodological quality are listed below. </p> </section> <section id="CD006111-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <section id="CD006111-sec-0030"> <h5 class="title">1. Randomisation</h5> <p>The authors graded this criterion as adequate (A), unclear (B), inadequate (C). Adequate (A) included any one of the following methods of randomisation: computer generated or table of random numbers; drawing of lots; coin‐toss; shuffling cards or throw of a dice. The authors judged as inadequate (C) methods of randomisation utilising any of the following: case record number; date of birth; or alternate numbers. </p> </section> <section id="CD006111-sec-0031"> <h5 class="title">2. Concealment of allocation</h5> <p>The authors graded this criterion as adequate (A), unclear (B), inadequate (C). Adequate (A) methods of allocation concealment included either central randomisation or sequentially numbered sealed opaque envelopes. The authors considered this criterion inadequate (C) if there was an open allocation sequence and the participants and trial authors could foresee the upcoming assignment. </p> </section> <section id="CD006111-sec-0032"> <h5 class="title">3<i>.</i> Blinding (of participants, researchers and outcome assessment) </h5> <p>We assessed blinding using the following criteria (detection and performance bias):</p> <p> <ol id="CD006111-list-0012"> <li> <p>blinding of participants (yes/no/unclear);</p> </li> <li> <p>blinding of caregiver (yes/no/unclear);</p> </li> <li> <p>blinding of outcome assessment (yes/no/unclear).</p> </li> </ol> </p> </section> <section id="CD006111-sec-0033"> <h5 class="title">4<i>.</i> Handling of withdrawals and losses </h5> <p>The authors graded this criterion as yes (A), unclear (B) and no (C) according to whether there was a clear description given of the difference between the two groups of losses to follow up (attrition bias). </p> </section> </section> <section id="CD006111-sec-0034"> <h4 class="title">Unit of analysis issues</h4> <p>We had intended following current practice for the meta‐analysis of data from trials using a cross‐over design, by utilising the methods suggested by Elbourne (<a href="./references#CD006111-bbs2-0017" title="ElbourneDR , AltmanDG , HigginsJP , CurtinF , WorthingtonHV , VailA . Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology2002;31(1):140-9.">Elbourne 2002</a>) but due to restrictions on the data that were available from the included studies we were not able to (quantitatively) analyse these data within this review. </p> </section> <section id="CD006111-sec-0035"> <h4 class="title">Dealing with missing data</h4> <p>We have been in contact with the authors of the Alvim trial, but to date have received no further information eligible for inclusion in the review (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>). </p> </section> <section id="CD006111-sec-0036"> <h4 class="title">Assessment of reporting biases</h4> <p>The paucity of included trials also precluded any planned attempts to assess publication bias through the use of a funnel plot. However, there was evidence from the retrieved results of the electronic searches, that there had been multiple publications of two of the included trials (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>; <a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>). </p> </section> <section id="CD006111-sec-0037"> <h4 class="title">Data synthesis</h4> <p>Advice was obtained from the Cochrane Cystic Fibrosis and Genetic Disorders Group regarding data synthesis. Any data which had been reported in the included trials and was relevant to the primary and secondary outcomes of this review were to be analysed by two authors (AAH and GOT) using RevMan 5 and reported according to Cochrane criteria (<a href="./references#CD006111-bbs2-0026" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). </p> </section> <section id="CD006111-sec-0038"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Clinical homogeneity of the included trials was assessed by examining the characteristics of the studies i.e.: the similarity between the types of participants, the interventions and the outcomes. However, because of intra‐trial heterogeneity in terms of: the characteristics of the participants; the dose and mode of administration of the intervention; and the outcomes reported, pooling of the results and meta‐analysis of the extracted data was not feasible and therefore this review only provides a descriptive summary of results of the individual trials. </p> </section> <section id="CD006111-sec-0039"> <h4 class="title">Sensitivity analysis</h4> <p>As there were insufficient included studies it was not possible to conduct any sensitivity analyses in this systematic review. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006111-sec-0040" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006111-sec-0040"></div> <section id="CD006111-sec-0041"> <h3 class="title">Description of studies</h3> <section id="CD006111-sec-0042"> <h4 class="title">Results of the search</h4> <p>The electronic searches retrieved five citations to two trials (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>; <a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>); three of these to the El‐Hazimi trial and two to the Alvim trial (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>; <a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>). The abstracts of these references were assessed independently by two of the authors (AAH/ZF). Scrutinisation of the bibliographical references of these papers identified an additional six references for which we obtained full text copies (<a href="./references#CD006111-bbs2-0004" title="De AraujoJT , NeroGS . Piracetam and acetamide in sickle-cell disease. Lancet1977;2(8034):411. ">De Araujo 1977</a>; <a href="./references#CD006111-bbs2-0005" title="De MeloGO . Piracetam in sickle cell anaemia. Lancet1976;2(7995):1139. ">De Melo 1976</a>; <a href="./references#CD006111-bbs2-0006" title="FranklinIM . Piracetam in sickle cell disease. Lancet1980;1(8143):767. ">Franklin 1980</a>; <a href="./references#CD006111-bbs2-0007" title="GiniEK , SonnetJ . Use of piracetam improves sickle cell deformability in vivo. Journal of Clinical Pathology1987;40(1):99-102. ">Gini 1987</a>; <a href="./references#CD006111-bbs2-0003" title="MikatiMA , SolhHM , DeryanDE , SahliIF , DabbousIA . A preliminary report on piracetam in sickle cell anemia: a double-blind crossover clinical trial and effects on erythrocyte survival. The King Faisal Specialist Hospital Medical Journal1983;3(4):233-6. ">Mikati 1983</a>; <a href="./references#CD006111-bbs2-0008" title="SonnetJ , GiniEK , CornuG . Trial prevention of vaso-occlusive crises in homozygote in sickle cell anemia using piracetam [Essai de prevention des crises vaso-occlusives de la drepanocytose homozygote par le piracetam]. Annales de la Société belge de médecine tropicale1985;65(1):77-84. ">Sonnet 1985</a>). Therefore, a total of eight potential studies were subjected to further evaluation. </p> </section> <section id="CD006111-sec-0043"> <h4 class="title">Included studies</h4> <p>Three randomised controlled trials, including 169 participants, met our inclusion criteria and were included in this review (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>; <a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>; <a href="./references#CD006111-bbs2-0003" title="MikatiMA , SolhHM , DeryanDE , SahliIF , DabbousIA . A preliminary report on piracetam in sickle cell anemia: a double-blind crossover clinical trial and effects on erythrocyte survival. The King Faisal Specialist Hospital Medical Journal1983;3(4):233-6. ">Mikati 1983</a>). Two trials had multiple publications (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>; <a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>). For the El Hazimi trial we chose to use the most recent published report of this trial in our review as it provided more complete data and trial details. The other references to this trial are listed as secondary references under the primary reference (<a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>). For the Avim trial we used the initial publication in 2005 as this was the primary reference; the 2009 reference was a supplementary publication (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>). </p> <section id="CD006111-sec-0044"> <h5 class="title">Alvim trial</h5> <p>The Alvim trial was a double‐blind, randomised, placebo‐controlled cross‐over trial conducted in Brazil from September 1998 to December 1999 (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>). A pilot study was carried out to determine the appropriate sample size and to test "the questionnaires and pain scores". The authors confirmed that this was an observational study and did not include any intervention. Several of the participants in the pilot study were also included in the clinical trial but all pain scores recorded during the pilot study were discarded at the start of the clinical trial. </p> <section id="CD006111-sec-0045"> <h6 class="title">Participants</h6> <p>A total of 80 participants were enrolled, but 7 were considered non‐compliant during the early part of the trial and were excluded from the analysis leaving 73 children (33 males) aged 5 to 20 years (median 12.1). All were suffering from sickle cell disease and were diagnosed as, Hb SS 42 (57.5%), HbSC 26 (35.5%), and 5 (7%) Hb Sß thalassaemia. The authors indicated that the genotype of participants enrolled in the trial was confirmed by haemoglobin electrophoresis but the diagnostic details were not reported. </p> <p>The trial authors specified as their inclusion criteria for this trial that all participants should have experienced moderate to severe painful crises defined as painful episodes of variable intensity and duration occurring in the limbs, vertebral spine and thorax or abdomen and which had been recognised by patients and carers as the typical pain attributable to the disease. Other painful events, i.e. priapism, avascular bone necrosis, osteomyelitis and acute chest syndrome were excluded. Additional exclusion criteria were: (1) renal, hepatic, cardiac or coagulation disorders secondary or not, to sickle cell disease; (2) regular blood transfusion, whatever the indication; (3) use of hydroxyurea; (4) age above 20 or below 5 years; (5) cognitive dysfunction that would hinder the reporting of pain<br/> Fifty of the participants had received one or more transfusions before the start of the trial, 5 (6.3%) had undergone splenectomy and a further five cholecystectomy. Acute splenic sequestration had occurred in 12 (15%), osteomyelitis in 11 (13.8%), aplastic crisis in one, and avascular necrosis of the femoral head in 4 (5%) participants. </p> </section> <section id="CD006111-sec-0046"> <h6 class="title">Interventions</h6> <p>Randomisation was to oral piracetam 4.8 g/m<sup>2</sup>/day every six hours or placebo. Piracetam was administered to half the participants and placebo to the other half for six months and these were crossed over for the following six months. The trial included a four‐week washout period, at cross‐over, consisting of a tapering off for two weeks followed by an additional two weeks without any medication. Compliance with the trial regimen was reinforced through regular home calls, evaluated by a pill count and monitored by regular urinary assay of piracetam levels. </p> </section> <section id="CD006111-sec-0047"> <h6 class="title">Outcomes</h6> <p>Participants or their carers, or both, completed weekly questionnaires which assessed the clinical status and symptoms of the participants. The questionnaires recorded aspects of general well‐being, the frequency length and type of painful crises, pain intensity and its site, the effect of the disease on school or work attendance, as well as sleeping, eating and other daily activities, the type of analgesia used and any need for ambulatory medical assistance or hospital admission. Pain intensity was assessed on a three‐point ordinal scale, (0 = no pain, 1 = bearable pain, 2 = unbearable pain), from which monthly pain scores were calculated. In addition clinicians completed monthly questionnaires, which recorded and characterised the painful crises and their treatment, during the course of the trial. </p> </section> </section> <section id="CD006111-sec-0048"> <h5 class="title">El‐Hazimi trial</h5> <p>The El‐Hazimi trial was a multicentre double‐blind, randomised, parallel group trial conducted from 1992 to 1994 in 13 centres in Saudi Arabia (<a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>). </p> <section id="CD006111-sec-0049"> <h6 class="title">Participants</h6> <p>A total of 101 children aged three to 12 years who had sickle cell disease (SCD and Hb S/ß thalassemia) were enrolled in the trial. The trial authors indicated that 16 dropped out at an early stage and that only 87 completed the trial. We have tried to contact the trial authors by electronic mail on several occasions to seek clarification of the discrepancy in the numbers of participants who were enrolled, those who dropped out and those who completed the trial but so far have received no response. The majority of the participants (79) were from the Western region of Saudi Arabia, where the Benin haplotype is prevalent, whilst the remainder (eight) were from the Eastern region, and had the Saudi Indian haplotype. </p> <p>Baseline data of sex, age, height, weight, number of crises, number of blood transfusions and hospitalisations, the 'Severity index' (<a href="./references#CD006111-bbs2-0018" title="El-HazmiMA , BahakimHM , al-SwailemAM , WarsyAS . The features of sickle cell disease in Saudi children. Journal of Tropical Pediatrics1990;36(4):148-55.">El‐Hazmi 1990</a>) and the 'Gini score' (<a href="./references#CD006111-bbs2-0007" title="GiniEK , SonnetJ . Use of piracetam improves sickle cell deformability in vivo. Journal of Clinical Pathology1987;40(1):99-102. ">Gini 1987</a>) were recorded at enrolment. The bibliographical reference quoted by the authors, to this 'score', does not provide any additional information and refers to an index of red cell deformability (IRCD) which does not appear to be directly related to the 'Gini score'. </p> <p>The trial authors indicated that at enrolment the diagnosis and classification of participants as SS or Sß0 thalassemia was based on the results of haemoglobin electrophoresis, red cell indices, HbA2 and Hb F levels but did not provide the values for these individual genotypes. </p> <p>The inclusion criteria for the trial specified that at entry the participants should have a disease severity greater than six as measured on the 'Severity index' (<a href="./references#CD006111-bbs2-0019" title="El-HazmiMAF , WarsyAS , Al MomenAK , HarakatiM . Hydroxyurea for the treatment of sickle cell disease. Acta Haematologica1992;88(4):170-4.">El‐Hazmi 1992</a>). This index, which was developed by the authors and does not appear to be internationally recognised, was designed to be used as a quantitative measure of the severity of sickle cell disease based on a combination of hematological, biochemical and clinical parameters consisting of six reversible and seven chronic complications which occur in sickle cell disease. </p> </section> <section id="CD006111-sec-0050"> <h6 class="title">Interventions</h6> <p>The participants were randomised to receive oral piracetam (48) or placebo (39) in a dose of 160 mg/kg/day but during any crisis they were admitted to hospital and received 300 mg/kg/day of piracetam or placebo by intravenous infusion. On discharge the participants were returned to their standard oral regimen. The report did not record if any tests of regimen compliance were carried out during the course of the trial. </p> </section> <section id="CD006111-sec-0051"> <h6 class="title">Outcomes</h6> <p>Clinical assessments were carried out routinely every 8 to 12 weeks during the trial period and included the recording of routine hematological and biochemical parameters, the point scores of which were added up to provide an annual 'Severity index'. During any admissions participants were assessed clinically and blood samples were taken for evaluation of hematological parameters. At the conclusion of the trial, all participants living in Riyadh were followed up every three months for the whole of the following year. </p> <p>Outcomes assessments for this trial were largely based on the 'Severity index' which consisted of a checklist of parameters which were described as possible reversible and chronic complications of sickle cell disease. Several of the items in this index were poorly defined and based on unsubstantiated assumptions of clinical status in sickle cell disease. Reversible complications included among others the number of transfusions received by participants but as clinical decisions for transfusion may be based on arbitrary criteria and not infrequently on the preferences of the individual clinician, this item might be considered an unreliable indicator of severity of sickle cell disease. Other items which were listed as chronic complications included cardiomyopathy, papillary necrosis and gallstones but were also equally ill‐defined and the authors did not clarify if any of these complications were detected as a result of symptoms or through routine screening, nor how they would be able to detect impotence in children under 12 years old. This index was developed by the authors as a quantitative measure of the severity of the sickle cell disease which they state that they found to be a useful measure to assess the beneficial effect or otherwise of the drug. However, the absence of a scaling capability of any of the individual items in this index may also reflect its poor sensitivity and competency to discriminate the degree in severity of individual pain crises. The authors also indicated that they used the 'Gini score' for evaluation of disease severity and whilst including data for both intervention groups in their report they did not provide any information on how this score was calculated or how the assessments were made. </p> </section> </section> <section id="CD006111-sec-0052"> <h5 class="title">Mikati trial</h5> <p>The Mikati trial consisted of a double‐blind cross‐over clinical trial and an 'experimental' study both of which were conducted in Lebanon between 1981 and 1982 (<a href="./references#CD006111-bbs2-0003" title="MikatiMA , SolhHM , DeryanDE , SahliIF , DabbousIA . A preliminary report on piracetam in sickle cell anemia: a double-blind crossover clinical trial and effects on erythrocyte survival. The King Faisal Specialist Hospital Medical Journal1983;3(4):233-6. ">Mikati 1983</a>). </p> <section id="CD006111-sec-0053"> <h6 class="title">Participants</h6> <p>Thirteen children aged 4 to 15 years, who were diagnosed with sickle cell disease by haemoglobin electrophoresis (Goldberg modification of the starch gel electrophoresis) (<a href="./references#CD006111-bbs2-0020" title="GoldbergCAJ . A new method for starch gel electrophoresis with special reference to the determination of hemoglobin A2. Clinical Chemistry1958;4:484.">Goldberg 1958</a>) entered the trial, but four dropped out because of irregular follow up which left nine children (five female, four male) who completed the trial. </p> </section> <section id="CD006111-sec-0054"> <h6 class="title">Interventions</h6> <p>In the clinical trial the participants received either piracetam I0 mg/kg/day orally in four daily doses, or placebo consisting of identical capsules which contained 300 mg lactose. The capsules were "chosen randomly" and the participants took them for five months, and then the interventions were crossed‐over for a similar period but no information about a washout period or any further trial details were provided by the authors. The 'experimental' study included in this report was an observational study which assessed the effects of piracetam on erythrocyte survival, in a separate group of participants and is therefore not included in this review. </p> </section> <section id="CD006111-sec-0055"> <h6 class="title">Outcomes</h6> <p>The stated primary outcome in this trial was the frequency of painful crises but the trial authors did not clarify how these were diagnosed or assessed. </p> </section> </section> </section> <section id="CD006111-sec-0056"> <h4 class="title">Excluded studies</h4> <p>We excluded five studies: a report of a non‐controlled study (<a href="./references#CD006111-bbs2-0004" title="De AraujoJT , NeroGS . Piracetam and acetamide in sickle-cell disease. Lancet1977;2(8034):411. ">De Araujo 1977</a>); an open study (<a href="./references#CD006111-bbs2-0005" title="De MeloGO . Piracetam in sickle cell anaemia. Lancet1976;2(7995):1139. ">De Melo 1976</a>); an in vitro study (<a href="./references#CD006111-bbs2-0006" title="FranklinIM . Piracetam in sickle cell disease. Lancet1980;1(8143):767. ">Franklin 1980</a>); a two part, in vitro and in vivo observational study (<a href="./references#CD006111-bbs2-0007" title="GiniEK , SonnetJ . Use of piracetam improves sickle cell deformability in vivo. Journal of Clinical Pathology1987;40(1):99-102. ">Gini 1987</a>); and an observational study (<a href="./references#CD006111-bbs2-0008" title="SonnetJ , GiniEK , CornuG . Trial prevention of vaso-occlusive crises in homozygote in sickle cell anemia using piracetam [Essai de prevention des crises vaso-occlusives de la drepanocytose homozygote par le piracetam]. Annales de la Société belge de médecine tropicale1985;65(1):77-84. ">Sonnet 1985</a>). </p> </section> </section> <section id="CD006111-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>Please refer to the Additional tables section of the review for information on the methodological quality of the included studies (<a href="#CD006111-tbl-0001">Table 1</a>). </p> <div class="table" id="CD006111-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Quality of included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Randomization</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Concealment</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Blinding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intention‐to‐treat</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Attrition</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clear (confirmed by email correspondence with authors)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inadequate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>To intervention: yes<br/>Outcomes assessment: yes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes, all participants included in the analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All dropouts were accounted for, 6 occurred at the beginning of the trial and 1 after 7 months. They were not included in the analysis </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adequate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>To intervention: yes<br/>Outcomes assessment: unclear </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No, only 87 out of 101 participants were analysed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dropouts occurred at an early stage of the trial but the stated number of participants completing the trial does not agree with the numbers enrolled minus the dropouts </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006111-bbs2-0003" title="MikatiMA , SolhHM , DeryanDE , SahliIF , DabbousIA . A preliminary report on piracetam in sickle cell anemia: a double-blind crossover clinical trial and effects on erythrocyte survival. The King Faisal Specialist Hospital Medical Journal1983;3(4):233-6. ">Mikati 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inadequate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>To intervention: yes<br/>Outcomes assessment: unclear </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes, all participants who completed the study were analysed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dropouts constituted &gt; 25% of the total</p> </td> </tr> </tbody> </table> </div> <section id="CD006111-sec-0058"> <h4 class="title">Allocation</h4> <section id="CD006111-sec-0059"> <h5 class="title">Alvim trial</h5> <p>The participants were randomly assigned to the intervention (oral piracetam) and control (placebo) groups; however, the method of randomisation was not specified in the report (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>). We wrote to the investigators who confirmed that randomization was achieved through the use of computer‐generated random numbers and only one investigator, who was not involved with clinical care, was aware of the code to the allocation sequence. Randomization was graded as (A) adequate, but because not all of the investigators were blinded to the allocation sequence this criterion was graded as inadequate (C). </p> </section> <section id="CD006111-sec-0060"> <h5 class="title">El‐Hazmi trial</h5> <p>The trial authors reported that participants received piracetam or placebo and that neither the participant nor clinicians were aware what the participant was receiving (<a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>). The active intervention (oral piracetam and intravenous infusion) and placebo (oral and intravenous infusion) were provided in coded boxes by the UCB Company; however, the method of randomisation of participants to active intervention or placebo was not specified and therefore this criterion was graded as unclear (B). The code to the allocation sequence was retained in the Head Office of the UCB Company in Brussels and therefore it was considered that adequate attempts had been made to conceal the allocation sequence from the trial authors. The deciphering of the allocation code only occurred at the end of the trial period and therefore this criterion was graded as adequate (A). </p> </section> <section id="CD006111-sec-0061"> <h5 class="title">Mikati trial</h5> <p>The trial authors reported that the interventions were 'randomly chosen' rather than individuals being randomised to intervention or control, they also failed to provide any information about the methods use to conceal the allocation sequence from either participants or trial authors and therefore both of these criteria were graded as inadequate (C) (<a href="./references#CD006111-bbs2-0003" title="MikatiMA , SolhHM , DeryanDE , SahliIF , DabbousIA . A preliminary report on piracetam in sickle cell anemia: a double-blind crossover clinical trial and effects on erythrocyte survival. The King Faisal Specialist Hospital Medical Journal1983;3(4):233-6. ">Mikati 1983</a>). </p> </section> </section> <section id="CD006111-sec-0062"> <h4 class="title">Blinding</h4> <section id="CD006111-sec-0063"> <h5 class="title">Alvim trial</h5> <p>The participants and researchers were blinded to intervention and control and the principal outcomes were self‐assessed therefore this criterion was graded as 'yes'. </p> </section> <section id="CD006111-sec-0064"> <h5 class="title">El‐Hazmi trial</h5> <p>The participants and investigators were blinded to intervention and control and therefore this criterion was graded as 'yes'. However, the trial authors did not clarify if the outcomes assessors were blinded to the interventions received by the participants and thus this criterion was graded as 'unclear'. </p> </section> <section id="CD006111-sec-0065"> <h5 class="title">Mikati trial</h5> <p>The capsules of active intervention and placebo were indistinguishable from each other and thus the investigators and participants were blinded to the interventions until after the completion of the trial and the analysis of its data, consequently this criterion was graded as 'yes'. </p> </section> </section> <section id="CD006111-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <section id="CD006111-sec-0067"> <h5 class="title">Alvim trial</h5> <p>Of the 80 participants enrolled in this clinical trial seven were considered non compliant, six of whom the authors confirmed did not attend scheduled clinic visits over the first two months of the trial. The remaining participant was excluded after seven months of difficult follow up and failure to attend for clinic visits. The early dropouts were not included in the analysis, and all those who completed the trial were included in the final analysis and therefore this criterion was graded as yes (A) </p> <p>The trial authors confirmed that although the active medication (piracetam) was donated by Biossintetica Laboratory and the placebo was manufactured by Ezequiel Dias Foundation, Health Department, Minas Gerais, neither of these two institutions had any active participation in the trial. Financial support for the trial was provided by FAPEMIG (State of Minas Gerais Research Foundation) and CNPq (Brazilian National Research Council) both of which are public institutions. </p> </section> <section id="CD006111-sec-0068"> <h5 class="title">El‐Hazmi trial</h5> <p>A total of 101 children aged three to 12 years who had sickle cell disease (SCD and Hb S/ß thalassemia) were enrolled in the trial and the trial authors indicated that 16 dropped out at an early stage and that only 87 completed the trial. The report of this trial provided a clear description of losses and withdrawals to the trial and thus this criterion was graded as yes (A); however, their data analyses did not follow the 'intention‐to‐treat' principle. </p> <p>The authors indicated that the drug and placebo, in addition to some unspecified help, were provided by UCB Company during the course of the trial (<a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>). </p> <p>Over and above the uncertainty of the 'Severity index' as a reliable and valid measure of severity in sickle cell disease crises, there are additional concerns about the methodological quality of this trial. These include the absence of a clear definition or criteria of a severe painful crisis, a major outcome in this trial, and no indication of the methods used to achieve standardisation of outcomes assessment between the trial authors in the 13 different centres. </p> </section> <section id="CD006111-sec-0069"> <h5 class="title">Mikati trial</h5> <p>All losses to the trial were accounted for therefore this criterion was graded as 'yes' (A), and the analysis of participants was to the treatment they were allocated. </p> <p>This trial included a 'clinical' and an 'experimental' study, but the reporting of trial details and data from these studies was scanty, unclear and somewhat confusing (<a href="./references#CD006111-bbs2-0003" title="MikatiMA , SolhHM , DeryanDE , SahliIF , DabbousIA . A preliminary report on piracetam in sickle cell anemia: a double-blind crossover clinical trial and effects on erythrocyte survival. The King Faisal Specialist Hospital Medical Journal1983;3(4):233-6. ">Mikati 1983</a>). No sample size or power calculation was performed for what was essentially a small sample study. The trial authors did not clarify the genotype of each participant at enrolment, and only stated that sickle cell anemia was confirmed by haemoglobin electrophoresis but did not include any diagnostic details. The duration of intervention in each trial arm was not clearly stated nor was there any indication of a washout period. The primary outcome sought in this trial was the frequency of painful crisis but the trial authors did not provide a definition or clarify their criteria for a painful crisis, nor how the severity of each crisis was to be assessed. </p> </section> </section> </section> <section id="CD006111-sec-0070"> <h3 class="title" id="CD006111-sec-0070">Effects of interventions</h3> <p>A limited amount of data addressing some of the primary, in addition to some of the secondary outcomes, was provided by all three of the included trials (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>; <a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>; <a href="./references#CD006111-bbs2-0003" title="MikatiMA , SolhHM , DeryanDE , SahliIF , DabbousIA . A preliminary report on piracetam in sickle cell anemia: a double-blind crossover clinical trial and effects on erythrocyte survival. The King Faisal Specialist Hospital Medical Journal1983;3(4):233-6. ">Mikati 1983</a>). These data, as discussed in '<a href="#CD006111-sec-0041">Description of studies</a>' and '<a href="#CD006111-sec-0057">Risk of bias in included studies</a>', are based on unvalidated assumptions used in the evaluation of outcomes, therefore we have not entered these data into the RevMan analyses but present the reported data within 'Additional tables' where appropriate (<a href="#CD006111-tbl-0002">Table 2</a>; <a href="#CD006111-tbl-0003">Table 3</a>). </p> <div class="table" id="CD006111-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Number of sickle cell crises (El‐Hazmi 1998)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Time points</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>3 ‐ 6 years (piracetam)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>3 ‐ 6 years (placebo)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>7 ‐ 12 years (piracetam)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>7 ‐ 12 years (placebo)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline Mean (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6 (3.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1 (3.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2 (1.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.2 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3 (2.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.3 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.5 (3.3)</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006111-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Number of hospitalisations (El‐Hazmi 1998)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Time points</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>3 ‐ 6 years (piracetam)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>3 ‐ 6 years (placebo)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>7 ‐ 12 years (piracetam)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>7 ‐ 12 years (placebo)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline Mean (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.5 (3.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.4 (3.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3 (3.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.9 (2.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.9 (2.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.2 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4 (2.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5 (2.0)</p> </td> </tr> </tbody> </table> </div> <section id="CD006111-sec-0071"> <h4 class="title">Primary outcomes</h4> <section id="CD006111-sec-0072"> <h5 class="title">1. Number of painful sickle cell disease crises</h5> <p>The average number of pain crises per participant per month reported in the Mikati trial was 0.89 with piracetam and 1.85 with placebo (P &lt; 0.05) (<a href="./references#CD006111-bbs2-0003" title="MikatiMA , SolhHM , DeryanDE , SahliIF , DabbousIA . A preliminary report on piracetam in sickle cell anemia: a double-blind crossover clinical trial and effects on erythrocyte survival. The King Faisal Specialist Hospital Medical Journal1983;3(4):233-6. ">Mikati 1983</a>). The severity of these crises was reportedly much less with active intervention than placebo but no data were available to confirm these results. </p> <p>The authors in the El‐Hazmi trial reported data for this outcome (<a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>). <i>See</i> 'Additional tables' (<a href="#CD006111-tbl-0002">Table 2</a>).<br/> The Alvim trial did not provide any separate data for the number of sickle cell crises or severity of pain but included these in a monthly global pain score which was calculated by combining data on the length and intensity of each episode during the trial (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>). However, it was not possible to unravel these data to provide information on the primary outcomes specified for this review. </p> </section> <section id="CD006111-sec-0073"> <h5 class="title">2<i>.</i> Mortality </h5> <p>None of the included trials provided data on mortality.</p> </section> </section> <section id="CD006111-sec-0074"> <h4 class="title">Secondary outcomes</h4> <section id="CD006111-sec-0075"> <h5 class="title">1. Pain: intensity and duration</h5> <p>Only the Alvim trial assessed pain severity but the data were included in a monthly pain score and not available as separate scores (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>). </p> </section> <section id="CD006111-sec-0076"> <h5 class="title">2. Requirement for opiate treatment</h5> <p>None of the included trials provided any data on requirement for opiate requirement.</p> </section> <section id="CD006111-sec-0077"> <h5 class="title">3. Serious complications</h5> <p>None of the included trials provided data on serious complications.</p> </section> <section id="CD006111-sec-0078"> <h5 class="title">4. Red cell dehydration</h5> <p>None of the included trials provided data on red cell dehydration.</p> </section> <section id="CD006111-sec-0079"> <h5 class="title">5. Number of other sickle‐related events</h5> <p>The only event reported was of one child with a deep ulcer on her cheek which was alleged to have improved dramatically during the course of the trial (<a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>). </p> </section> <section id="CD006111-sec-0080"> <h5 class="title">6. Quality of life</h5> <p>Only generalised and subjective improvements were reported, none of which were supported by any validated instruments. </p> </section> <section id="CD006111-sec-0081"> <h5 class="title">7. Hospitalisation</h5> <p>In the Alvim trial, the number of days of hospitalisation ranged from 0 to 42 (median 1) and in 93.5% a painful crisis was involved but there was no significant difference between the piracetam and placebo periods for the number of days of hospitalisation (P = 0.87). </p> <p>Data for the number of hospitalisations were reported in the El‐Hazimi trial (<a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>). <i>See</i> 'Additional tables' (<a href="#CD006111-tbl-0003">Table 3</a>). </p> </section> <section id="CD006111-sec-0082"> <h5 class="title">8<i>.</i> Satisfaction with medication </h5> <p>The authors in the Alvim trial reported that nearly all participants and their relatives indicated their satisfaction with the clinical course of the trial, but no details were provided about how this was evaluated or the type of questionnaire or assessment tool that was employed (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>). El‐Hazmi indicated that parents of the participants insisted on continuation of therapy, thereby showing their satisfaction but provided no details as to how this satisfaction had been assessed (<a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>). </p> </section> </section> <section id="CD006111-sec-0083"> <h4 class="title">Adverse effects</h4> <p>No clinical or laboratory evidence of toxicity to piracetam was reported in either the Alvim or the El‐Hazmi trial (<a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a>; <a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a>). The authors in the Mikati trial reported that one participant experienced dizziness with the drug (<a href="./references#CD006111-bbs2-0003" title="MikatiMA , SolhHM , DeryanDE , SahliIF , DabbousIA . A preliminary report on piracetam in sickle cell anemia: a double-blind crossover clinical trial and effects on erythrocyte survival. The King Faisal Specialist Hospital Medical Journal1983;3(4):233-6. ">Mikati 1983</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006111-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006111-sec-0084"></div> <p>The lack of reliable evidence for the effectiveness of piracetam is illustrated by the paucity of trials retrieved for this review. However, the wide divergence of reported results in the included trials and the apparent lack of popularity of this drug by clinicians over the past 20 years would appear to suggest and possibly confirm some of the uncertainty in the effectiveness of this medication in preventing painful sickle cell crises. </p> <p>The episodic nature of sickle cell crisis pain, with its propensity to affect multiple sites, difficulties in conducting pain prevention studies in sickle cell disease, the relatively subjective nature of observer‐rated pain intensity, and the absence of a drug which meets a 'gold standard' that can be compared to either piracetam or any other known compounds with established effectiveness in preventing or reducing pain in sickle cell crises by treating the sickling process, sets challenges for any future trials of effectiveness of this specific medication. </p> <p>We will continue to run searches on a two‐yearly cycle to identify any potentially relevant trials; however, we do not plan to update other sections of this review until new trials are published. </p> </section> </section> <div class="tables-list"> <div class="table"> <table data-id="CD006111-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Quality of included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Randomization</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Concealment</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Blinding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intention‐to‐treat</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Attrition</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006111-bbs2-0001" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228-33. VianaMB , AlvimRC . Painful crises in children with sickle cell disease are not prevented by piracetam. Acta Haematologica2009;121(1):9-10. ">Alvim 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clear (confirmed by email correspondence with authors)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inadequate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>To intervention: yes<br/>Outcomes assessment: yes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes, all participants included in the analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All dropouts were accounted for, 6 occurred at the beginning of the trial and 1 after 7 months. They were not included in the analysis </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006111-bbs2-0002" title="El-HazmiM , Al-FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children - a double blind test. Saudi Medical Journal1998;19(1):22-7. El-HazmiMA , WarsyAS , Al-FawazI , FaridM , RefaiS , OpawoyeAO , et al. Piracetam in the treatment of sickle cell disease [abstract]. In: The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March. 1995:162. El-HazmiMA , WarsyAS , Al-FawazI , OpawoyeAO , Abu TalebH , HowsawiZ , et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematologica1996;96(4):221-6. ">El‐Hazmi 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adequate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>To intervention: yes<br/>Outcomes assessment: unclear </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No, only 87 out of 101 participants were analysed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dropouts occurred at an early stage of the trial but the stated number of participants completing the trial does not agree with the numbers enrolled minus the dropouts </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006111-bbs2-0003" title="MikatiMA , SolhHM , DeryanDE , SahliIF , DabbousIA . A preliminary report on piracetam in sickle cell anemia: a double-blind crossover clinical trial and effects on erythrocyte survival. The King Faisal Specialist Hospital Medical Journal1983;3(4):233-6. ">Mikati 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inadequate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>To intervention: yes<br/>Outcomes assessment: unclear </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes, all participants who completed the study were analysed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dropouts constituted &gt; 25% of the total</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Quality of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006111.pub3/full#CD006111-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006111-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Number of sickle cell crises (El‐Hazmi 1998)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Time points</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>3 ‐ 6 years (piracetam)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>3 ‐ 6 years (placebo)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>7 ‐ 12 years (piracetam)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>7 ‐ 12 years (placebo)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline Mean (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6 (3.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1 (3.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2 (1.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.2 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3 (2.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.3 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.5 (3.3)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Number of sickle cell crises (El‐Hazmi 1998)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006111.pub3/full#CD006111-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006111-tbl-0003"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Number of hospitalisations (El‐Hazmi 1998)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Time points</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>3 ‐ 6 years (piracetam)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>3 ‐ 6 years (placebo)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>7 ‐ 12 years (piracetam)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>7 ‐ 12 years (placebo)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline Mean (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.5 (3.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.4 (3.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3 (3.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.9 (2.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.9 (2.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.2 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4 (2.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5 (2.0)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Number of hospitalisations (El‐Hazmi 1998)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006111.pub3/full#CD006111-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006111.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"/> </noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006111-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006111-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD006111-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD006111-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD006111-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006111-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"/> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"/> </a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006111\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006111\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006111\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006111\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006111\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006111.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006111.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006111.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006111.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006111.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726563281"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006111.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726563288"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006111.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e96b33cf2f3c9',t:'MTc0MDcyNjU2My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 